Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2020, Vol. 47 Issue (3): 405-408    DOI: 10.31083/j.ceog.2020.03.5239
Case Report Previous articles | Next articles
Intrauterine balloon failure: unrecognized placenta accreta spectrum disorders
K. Tamura1, H. Takahashi1, *(), S. Uchida1, M. Ogoyama1, R. Usui1, S. Matsubara1
1Department of Obstetrics and Gynecology, Jichi Medical University, Tochigi, Japan
Download:  PDF(513KB)  ( 167 ) Full text   ( 3 )
Export:  BibTeX | EndNote (RIS)      
Abstract  

Several studies indicate that intrauterine balloon (IUB) use is less effective for postpartum hemorrhage (PPH) due to placenta accreta spectrum (PAS) disorders than that due to atonic bleeding. IUB failed to achieve hemostasis because the present two cases had normally positioned PAS. Case Report: A 37-year-old woman was transferred due to PPH. She vaginally delivered. The placenta was without macroscopic defect. Atonic bleeding was suspected. An IUB was placed, without achieving hemostasis. Her status deteriorated, necessitating a hysterectomy. The placenta remained, adhering to the uterine body. Histological examination revealed placenta accreta. The second case was a 40-year-old woman that was transferred due to PPH of atonic bleeding after vaginal delivery. The placenta was without macroscopic defect. An IUB was placed, without hemostasis, and was subsequently was removed. Conservative treatment achieved hemostasis. An Ultrasound revealed the placenta in the uterine body. We diagnosed her with clinical PAS. Nonprevia PAS may be present when an IUB fails to achieve hemostasis.

Key words:  Intrauterine balloon      Hysterectomy      Postpartum hemorrhage      Placenta accreta spectrum      Transfusion     
Submitted:  22 April 2019      Accepted:  24 June 2019      Published:  15 June 2020     
*Corresponding Author(s):  HIRONORI TAKAHASHI     E-mail:  hironori@jichi.ac.jp

Cite this article: 

K. Tamura, H. Takahashi, S. Uchida, M. Ogoyama, R. Usui, S. Matsubara. Intrauterine balloon failure: unrecognized placenta accreta spectrum disorders. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(3): 405-408.

URL: 

https://ceog.imrpress.com/EN/10.31083/j.ceog.2020.03.5239     OR     https://ceog.imrpress.com/EN/Y2020/V47/I3/405

Figure 1.  — Clinical course of Case 1. The blood loss (vaginal + from intrauterine balloon drain) steadily increased to as much as 300 mL at one hour after intrauterine balloon use (bold arrow). CS: cesarean section, TAE: transarterial embolization.

Figure 2.  — Macroscopic (a) and microscopic (b) findings in Case 1. Placenta accreta spectrum is observed. A placental fragment adhered to the posterior uterine body (arrow). Chorionic villi directly attached to the myometrium (arrowhead) without decidua, suggesting placenta accreta.

Figure 3.  — Imaging findings in Case 2. Transvaginal ultrasound shows the residual placenta (high-echoic part: star) in the uterus on postpartum day 8. The placenta is retained in the anterior uterus (asterisk) based on magnetic resonance imaging (T1 gadolinium enhanced) on postpartum day 10.

[1] Revert M., Cottenet J., Raynal P., Cibot E., Quantin C., Rozenberg P.: “Intrauterine balloon tamponade for management of severe postpartum haemorrhage in a perinatal network: a prospective cohort study”. BJOG, 2017, 124, 1255.
doi: 10.1111/1471-0528.14382 pmid: 27781401
[2] Vintejoux E., Ulrich D., Mousty E., Masia F., Mares P., de Tayrac R., et al.: “Success factors for Bakri™ balloon usage secondary to uterine atony: a retrospective, multicentre study”. Aust. N. Z. J. Obstet. Gynaecol., 2015, 55, 572.
doi: 10.1111/ajo.12376 pmid: 26223852
[3] Ogoyama M., Takahashi H., Usui R., Baba Y., Suzuki H., Ohkuchi A., et al.: “Hemostatic effect of intrauterine balloon for postpartum hemorrhage with special reference to concomitant use of “holding the cervix” procedure (Matsubara)”. Eur. J. Obstet. Gynecol. Reprod. Biol., 2017, 210, 281.
doi: 10.1016/j.ejogrb.2017.01.012 pmid: 28088108
[4] Kong C.W., To W.W.: “Prognostic factors for the use of intrauterine balloon tamponade in the management of severe postpartum hemorrhage”. Int. J. Gynaecol. Obstet., 2018, 142, 48.
doi: 10.1002/ijgo.12498 pmid: 29603742
[5] Georgiou C.: “Balloon tamponade in the management of postpartum haemorrhage: a review”. BJOG, 2009, 116, 748.
doi: 10.1111/j.1471-0528.2009.02113.x pmid: 19432563
[6] Brown H., Okeyo S., Mabeya H., Wilkinson J., Schmitt J.: “The Bakri tamponade balloon as an adjunct treatment for refractory postpartum hemorrhage”. Int. J. Gynaecol. Obstet., 2016, 135, 276.
doi: 10.1016/j.ijgo.2016.06.021 pmid: 27612530
[1] H.M. Kim, J.Y. Lee, W.J. Seong. Multidetector computed tomography to predict heavy bleeding and need for angiographic embolization in patients with postpartum hemorrhage[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 478-482.
[2] L. Xie, X. Ru, Y. Xu, Y.F. Ouyang, S.Y. Shu. A low birth weight infant with unexpected hepatic artery pseudoaneurysm rupture: A case report and review of the literature[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(3): 455-458.
[3] H.Y. Zhang, Y. Wu, R. Guo, M. Huang, Y. Ling, Y.H. Huang. Less Residual placental blood volume left when cord pulsation ceases than when early cord clamping at 60 seconds[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 202-207.
[4] D. Jovanovic, D. R. Milovanovic, I. Jovanovic, M. Folic, V. Jakovljevic. Influence of cytokines on the postoperative period[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(1): 31-36.
[5] H. Takahashi, Y. Baba, M. Ogoyama, H. Suzuki, A. Ohkuchi, R. Usui, S Matsubara. Does previous cesarean section per se, especially its number, increase the risk of allogeneic blood transfusion at cesarean section for placenta previa?[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(1): 41-46.
[6] K. Lee, S. Lee, H. N. Lee, H. Lim, I. J. Kim, I. Y. Park, M. J. Kim. Uterine necrosis following selective embolization for postpartum hemorrhage: report of four cases and review of literature[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(6): 1020-1025.
[7] D. Damnjanovic, M. Zamurovic, D. Zamurovic, S. Krusic. Liver rupture as a complication in cardiopulmonary resuscitation for cardiac arrest after vaginal hysterectomy[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(6): 1031-1033.
[8] E. Chalari, G. Intas, S. Zyga, G. Fildissis, M. Tolia, N. Tsoukalas, A. Yfantis, G. Kyrgias, G. Panoutsopoulos. Preoperative factors affecting the intraoperative core body temperature in elective hysterectomy under general anesthesia[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(4): 560-564.
[9] K. Nakamura, K. Nakayama, T. Minamoto, T. Ishibashi, K. Sanuki, H. Yamashita, R. Ono, H. Sasamori, S. Razia, M.M. Hossain, S. Kamrunnahar, M. Ishikawa, S. Kyo. A novel retrograde approach for total laparoscopic hysterectomy in patients with severe adhesion in the cul-de-sac[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(4): 565-569.
[10] M. Simonsen, L. Martins Campbell, R. Moretti Marques. Uterine manipulator – low budget option[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(4): 575-577.
[11] A. Klimczak, G. Kilic, B. S. Unlu, Y.-L. Lin, Y.-F. Kuo, M. Borahay. Pelvic organ prolapse surgery after different hysterectomy methods: a population-based cohort study[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(3): 466-472.
[12] A. Daniilidis, K. Chatzistamatiou, M. Siskou, Ü. Kalkan, T. Theodoridis, S. Angioni. Vault prolapse occurrence after total laparoscopic hysterectomy and total abdominal hysterectomy performed for benign indications, is there a difference? A systematic review of the literature[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(2): 183-185.
[13] Ichiro Miwa, Masahiro Shinagawa, Terumi Miwa, Keiko Ootani, Masakatsu Sase, Yasuhiko Nakamura. Severe postpartum hemorrhage with placental abruption managed by the uterine sandwich: a case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(2): 289-290.
[14] M. Meléndez Zalduegui, S. Iglesias Ferreiro, A. Rodríguez Vélez, ML. Monje Beltrán, EM. Vicedo Madrazo, RJ. Martínez Portillo, M. Llobet Roma, M. Marqueta Sánchez. Cesarean scar ectopic pregnancy, a life threatening condition: a case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(2): 313-316.
[15] G. Sukgen. Laparoscopic hysterectomy with anterior four-arm mesh implant technique in the surgical treatment of a woman with pelvic organ prolapse and urinary incontinence: a case report and review of the literature[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(1): 161-163.
No Suggested Reading articles found!